On December 21, 2022, Bill Weber resigned from his position as co-ChiefExecutive Officer, Director and Chairman of the Board of Directors (the Board) of First Light Acquisition Group, Inc. (the Company), effective immediately. Mr. Weber's resignation was not the result of any disagreement with the Company relating to the Company's operations, policies or practices. Effective as of December 22, 2022, Thomas A. Vecchiolla will serve as sole Chief Executive Officer and Chairman of the Board.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2375 USD | +5.18% | -0.63% | -84.27% |
Apr. 16 | Calidi Biotherapeutics Prices $6.1 Million Offering | MT |
Mar. 21 | H.C. Wainwright Lowers Price Target on Calidi Biotherapeutics to $2 From $11, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.27% | 11.06M | |
+7.38% | 111B | |
+11.13% | 106B | |
-12.46% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.79% | 16.81B | |
+37.54% | 12.54B | |
-24.36% | 8.09B |
- Stock Market
- Equities
- CLDI Stock
- News Calidi Biotherapeutics, Inc.
- First Light Acquisition Group, Inc. Announces Resignation of Bill Weber as Co-Chiefexecutive Officer, Director and Chairman of the Board of Directors